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▼Often, it is of interest to have a reporter in which tran-
scription is controlled. Although many eukaryotic promot-
ers have been identified and cloned, they are often leaky
and/or lack responsiveness in mammalian cell lines. More-
over, the inducers are generally deleterious to the host cell
or have significant drawbacks. Many chimeric transcription
factors have been developed to ameliorate these problems.
Early attempts at producing chimeric transcription factors
used the glucocorticoid receptor (Ref. 1). More recently, the
bacterial lac and tet operons have been exploited. The tet-
based systems are not as ‘leaky’ as their lac-based counter-
parts.
Two tetracycline (Tc)-responsive binary systems have
been described (Ref. 2, 3). Both utilize a regulatory sequence
composed of a heptameric repeat of the tetO 19 bp inverted
repeat fused to the immediate early sequences of the cy-
tomegaloviral enhancer (tetO7CMV).
The systems differ in kinetics related to the addition
of Tc based on the modified chimeric transcription fac-
tor utilizing the Tc resistence protein (tetR). The chimera
presently referred to as tTA is composed of the tetR pro-
tein, fused to the so-called ‘transactivating’ C-terminus
of the co-adaptor protein, VP-16, from HSV-1. Whereas
the tetRKRAB chimera consists of the highly conserved
Kruppel-associated box (KRAB) domain of the Kox1 zinc-
finger protein family fused to the tetracycline repressor pro-
tein. Accordingly, the motifs differ in their kinetics and
mechanism of associations. The tTA system is induced by
the absence of Tc. In the uninduced state, basal levels of
expression tend to be relatively high, owing to the CMV
sequences. The tetRKRAB system makes use of the tran-
scriptional silencing influence of the KRAB domain. This
system maintains much lower levels of basal activity in the
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repressed state and is induced by the addition of Tc. Never-
theless, to date, induction levels are much lower than that
observed in the tTA.
The bacterial β-galactosidase gene (lacZ) is an excellent
reporter used extensively in life-science applications includ-
ing: cloning (Ref. 4); promoter assessment (Ref. 5); and mu-
tation analysis (Ref. 6). lacZ is often the reporter of choice
as it provides straightforward results regarding expression
and function, while quantitation of the protein is easily
attained by spectrophotometric analysis.
In this article, we describe a mammalian reporter plas-
mid, TK(tetO)7CMV-lacZ (Figure 1) that is Tc-responsive
when transfected with an expression vector coding for the
chimeric repressing protein (tetRKRAB). This construct con-
tains an upstream thymidine kinaseminimal promoter (TK-
HSV), followed by a regulatory element, composed of a hep-
tameric tet-operator from the Tc-resistance operon encoded
in Tn10 Escherichia coli, combined with the immediate early
sequences from the cytomegaloviral enhancer. By combin-
ing the TK and CMV promoters, we observe significant in-
duction levels while maintaining excellent repression levels
in the uninduced state.
Materials and methods
TK-tetO7CMV-lacZ Construction
The parent vector of the reporter, pCH110 (Pharmacia
Biotech Inc., Piscataway, NJ) was modified earlier (Ref. 7).
Briefly, this vector, pTKbgal, is a pBR322 plasmid contain-
ing an upstream TK minimal promoter, followed by a mul-
tiple cloning site that is upstream of the lacZ gene.
The ptetO7-CMV-luc (Ref. 3) construct, containing the
tetO7-CMV operator, is used as template for PCR. The up-
stream primer, 2HU introduces a HindIII restriction site,
while the downstream primer 1HD sequence incorporates
the existing HindIII site in the template (ptetO7-CMV-luc),
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FIGURE 1. Cloning of pTK(tetO)7CMV-lacZ. (a) The heptameric (tetO)CMV cis sequence from ptetO7-CMV-luc containing flanking HindIII sites was
produced using PCR. The upstream primer (1HU) introduced an upstream HindIII site while the downstream primer (2HD) incorporated an existing
HindIII site contained in the template. The PCR product, a 1.2 kb heterologous operator region flanked by HindIII, was ligated into the HindIII site of the
MCS in pTK-lacZ. (b) The restriction map of TK(tetO)7CMV-lacZ. The HindIII restriction sites were inactivated upon ligation.
as shown in Figure 1a. The tetO7-CMV 1.2 Kb PCR fragment
is digested and inserted at the HindIII site, downstream of
the TK minimal promoter (Figure 1b), yielding the lacZ re-
porter TKtetO7CMV-lacZ (Figure 1b).
Cell culture and lipofection
HeLa or NIH 3T3 cells are cultured in [Iscove’s DMEM (5%
fetal bovine serum) Life Technologies, Inc., Gaithersburg,
MD, USA] or [DMEM media (10% calf serum) Life Tech-
nologies, Inc., Gaithersburg, MD, USA] respectively. All our
culturing reagents were obtained from the same manufac-
turer.
The DNA used during transfections consists of puri-
fied plasmids, Qiagen midi prep protocol (Qiagen Inc.,
Chatsworth, VA, USA). DNA is transfected using Lipofec-
tamine (Life Technologies, Inc., Gaithersburg, MD, USA) at
various ratios of CMVtetR-KRAB: TK-tetO7CMV-lacZ. The
cultures are washed and provided with fresh media 4–5
hours after transfection. Media containing Tc (0.5 µg/ml)
is added to some cultures.
Assay for β-galactosidase activity
β-galactosidase activity is measured using the β-
galactosidase assay kit (Stratagene, La Jolla, CA, USA)
and the substrate o-nitrophenyl-β-D-galactopyranoside
(ONPG). Because the bacterial β-galactosidase is less labile
than the mammalian counterpart, all lysates, are placed at
44◦C for 40 minutes before the addition of the substrate in
order to reduce endogenous activity. All samples are nor-
malized using a modified Lowry stain (Bio-Rad, Hercules,
CA, USA).
Results and discussion
By placing the (tetO)7CMV downstream of the TK and
upstream of the lacZ, we reasoned that in the repressed
state, TK promotion would be inhibited by the bulky
tetR–KRAB–DNA complexes. However, when these inter-
actions are destabilized by the addition of Tc, the TK and
CMV promotion would display synergism. This seems to be
the case. In transiently transfected HeLa cells, induction is
well in excess of 100-fold.
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FIGURE 2. Tetracycline- (Tc)-responsiveness of transiently
transfected HeLa cells over time. HeLa cells, derived from one culture,
were seeded in 60 mm diameter petri plates, transfected at 80%
confluency and were not split throughout the experiment. Cells were
transiently cotransfected with a molar ratio of 4:1, ptetRKRAB to
pTK(tetO)7CMV-lacZ. Tc (0.5 µg/ml) was added to two of three
transfected cultures while one culture was maintained without Tc. In
order to display effects from transfection efficiency, data were not
combined.
Neither the TK or the CMV sequences in any way change
the transcriptional start sites within any cDNA. Various
host proteins known as adapters or co-activators recog-
nize these DNA elements. Upon association with these pro-
teins, a conformational change within the DNA ensues.
This change in conformation is thought to facilitate the re-
cruitment of various proteins involved in the formation of
the pre-initiation complex (PIC). Thus, the observed effect
of such promoters, commonly used in genetic engineering,
is the increased rate of transcription of reporter genes, in
this case of the lacZ.
It is our contention that the protein–DNA interactions
between the tetRKRAB–(tetO) thwart the ability of the
TK and CMV to become associated with adaptor or co-
activator proteins. Naturally, the mechanism of ‘thwarting’
the promoter activity must also lie within the probable in-
duced change in the DNA conformation arising from the
tetRKRAB–(tetO) interactions.
By combining the CMV and TK promotion we observe:
(1) a quick response to Tc addition; and (2) a high induc-
tion level, as much as 25 times that observed for tetO7CMV
reporters lacking the upstream TK promoter during cotrans-
FIGURE 3. Responsiveness after transient transfection of NIH 3T3
cells with low ratio repressor:expression plasmid. NIH3T3 cells,
derived from one culture, were seeded in 60 mm diameter petri plates,
transfected at 80% confluency and were not split throughout the
experiment. Cells were transiently cotransfected with a molar ratio of
1.5, tetRKRAB repressor to pTK(tetO)7CMV-lacZ expression vector.
Tetracycline (Tc; 0.5 µg/ml) was added to four of six transfected
cultures while two cultures were maintained without Tc and two
additional cultures were ‘mock’ transfected.
fection with ptetRKRAB (Ref. 3; U. Deuschle, pers. com-
mun.). Additionally, we have not compromized the excel-
lent repression of the tetR-KRAB by the addition of the up-
stream TK promoter.
As shown in Figure 2, upon transient transfection of our
reporter plasmid with the ptetRKRAB, high levels of induc-
tion are reached by 22 h after addition of Tc. Levels of in-
duction are in the range of 50–300-fold, usually by hour 19
(data not shown). In one particular experiment, extremely
high levels of induction (>100 fold) were reached by 9.5
hours after transfection. In most cases, however, by 6–9 h,
induction levels are within the range of tenfold.
Naturally, the ratio of repressor to expression plasmid
will effect overall expression and induction levels. Typi-
cally, as much as five to ten times as much repressor is
used during transient cotransfection (Ref. 2, 3). We found
that when using a low ratio of repressor:expression plasmid
(1.5), by 4.5 hours as much as a threefold level of induction
was achieved (Figure 3). However, as expected, basal levels
in the uninduced state were significantly higher than that
observed when using a higher ratio (Figure 2).
The reproducibility and efficacy of this systemwill proba-
bly be subject to host cell-line variances. Notably, BHK and
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Vero cell lines have been shown to display from 10–580-
fold higher levels of induction than HeLa and PC12 lines
using the tetO7CMV operator and the tTA transactivating
protein (Ref. 2).
Other Tc repressor-based fusion (and non fusion) pro-
teins should also recognize this reporter vector. The use of
the tetR-VP16 transactivating protein and TK-tetO7CMV-
lacZ should result in an inverse pattern of induction rela-
tive to Tc. Furthermore, the TK(tetO)7CMV switch might
be suitable for use with other cDNAs.
Because the origins of the chimeric factor include
the KRAB repression domain, which is highly conserved
amongst mammals, possible non-specific interaction with
other cis-sequences could occur. Such predicted interac-
tions have been observed in the original tTA system. How-
ever, the KRAB domain does not display attraction to the
TK promoter, especially when fused to either the Gal4 acti-
vator protein (Ref. 8) or the tetR protein (Ref. 3).
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Products Used
pCH110: pCH110 from Pharmacia
Fetal bovine serum: Fetal bovine serum from Life
Technologies (Gibco BRL)
Qiagen midi prep: Qiagen midi prep from QIA-
GEN GmbH
lipofectAMINE: lipofectAMINE from Life Tech-
nologies (Gibco BRL)
lipofectAMINE: lipofectAMINE from Life Tech-
nologies (Gibco BRL)
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